GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » Days Payable

Harbin Pharmaceutical Group Co (SHSE:600664) Days Payable : 119.59 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co Days Payable?

Harbin Pharmaceutical Group Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥3,887 Mil. Harbin Pharmaceutical Group Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥2,966 Mil. Hence, Harbin Pharmaceutical Group Co's Days Payable for the three months ended in Mar. 2024 was 119.59.

The historical rank and industry rank for Harbin Pharmaceutical Group Co's Days Payable or its related term are showing as below:

SHSE:600664' s Days Payable Range Over the Past 10 Years
Min: 119.38   Med: 136.36   Max: 159.79
Current: 123.06

During the past 13 years, Harbin Pharmaceutical Group Co's highest Days Payable was 159.79. The lowest was 119.38. And the median was 136.36.

SHSE:600664's Days Payable is ranked better than
66.53% of 971 companies
in the Drug Manufacturers industry
Industry Median: 89.17 vs SHSE:600664: 123.06

Harbin Pharmaceutical Group Co's Days Payable increased from Mar. 2023 (111.53) to Mar. 2024 (119.59). It may suggest that Harbin Pharmaceutical Group Co delayed paying its suppliers.


Harbin Pharmaceutical Group Co Days Payable Historical Data

The historical data trend for Harbin Pharmaceutical Group Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Pharmaceutical Group Co Days Payable Chart

Harbin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 139.09 159.79 133.62 122.67 119.38

Harbin Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.53 122.91 127.24 125.77 119.59

Competitive Comparison of Harbin Pharmaceutical Group Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Pharmaceutical Group Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's Days Payable falls into.



Harbin Pharmaceutical Group Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Harbin Pharmaceutical Group Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (3509.947 + 3950.622) / 2 ) / 11404.77*365
=3730.2845 / 11404.77*365
=119.38

Harbin Pharmaceutical Group Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (3950.622 + 3822.657) / 2 ) / 2965.588*365 / 4
=3886.6395 / 2965.588*365 / 4
=119.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Harbin Pharmaceutical Group Co Days Payable Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Pharmaceutical Group Co (SHSE:600664) Business Description

Traded in Other Exchanges
N/A
Address
Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.
Executives
Lin Guo Ren senior management
Wang Hai Sheng senior management
Liu Bo senior management
Meng Xiao Dong senior management
Xu Hai Ying Directors, senior managers
Liang Chen senior management
Wang Peng Hao senior management
Xiao Qiang senior management
Wei Shuang Ying senior management
Zhou Xing senior management
Bian Ke Supervisors
Sha Mei senior management
Jian Shi Hui Zhu Xi Supervisors
Wang Zhi Fu Supervisors
Jiang Lu Director

Harbin Pharmaceutical Group Co (SHSE:600664) Headlines

No Headlines